Literature DB >> 18764821

Chemical and biological folding contribute to temperature-sensitive DeltaF508 CFTR trafficking.

Xiaodong Wang1, Atanas V Koulov, Wendy A Kellner, John R Riordan, William E Balch.   

Abstract

Proteostasis (Balch WE, Morimoto RI, Dillin A, Kelly JW. Adapting proteostasis for disease intervention. Science 2008;319:916-919) refers to the biology that maintains the proteome in health and disease. Proteostasis is challenged by the most common mutant in cystic fibrosis, DeltaF508, a chloride channel [the cystic fibrosis transmembrane conductance regulator (CFTR)] that exhibits a temperature-sensitive phenotype for coupling to the coatomer complex II (COPII) transport machine for exit from the endoplasmic reticulum. Whether rescue of export of DeltaF508 CFTR at reduced temperature simply reflects energetic stabilization of the chemical fold defined by its primary sequence or requires a unique proteostasis environment is unknown. We now show that reduced temperature (30 degrees C) export of DeltaF508 does not occur in some cell types, despite efficient export of wild-type CFTR. We find that DeltaF508 export requires a local biological folding environment that is sensitive to heat/stress-inducible factors found in some cell types, suggesting that the energetic stabilization by reduced temperature is necessary, but not sufficient, for export of DeltaF508. Thus, the cell may require a proteostasis environment that is in part distinct from the wild-type pathway to restore DeltaF508 coupling to COPII. These results are discussed in the context of the energetics of the protein fold and the potential application of small molecules to achieve a proteostasis environment favoring export of a functional form of DeltaF508.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18764821      PMCID: PMC2683680          DOI: 10.1111/j.1600-0854.2008.00806.x

Source DB:  PubMed          Journal:  Traffic        ISSN: 1398-9219            Impact factor:   6.215


  100 in total

1.  p97 functions as an auxiliary factor to facilitate TM domain extraction during CFTR ER-associated degradation.

Authors:  Eric J Carlson; David Pitonzo; William R Skach
Journal:  EMBO J       Date:  2006-09-14       Impact factor: 11.598

2.  F508del CFTR with two altered RXR motifs escapes from ER quality control but its channel activity is thermally sensitive.

Authors:  Tamás Hegedus; Andrei Aleksandrov; Liying Cui; Martina Gentzsch; Xiu-Bao Chang; John R Riordan
Journal:  Biochim Biophys Acta       Date:  2006-03-31

Review 3.  Cystic fibrosis enters the proteomics scene: new answers to old questions.

Authors:  Mario Ollero; Franck Brouillard; Aleksander Edelman
Journal:  Proteomics       Date:  2006-07       Impact factor: 3.984

4.  Slc26a6 regulates CFTR activity in vivo to determine pancreatic duct HCO3- secretion: relevance to cystic fibrosis.

Authors:  Youxue Wang; Abigail A Soyombo; Nikolay Shcheynikov; Weizhong Zeng; Michael Dorwart; Christopher R Marino; Philip J Thomas; Shmuel Muallem
Journal:  EMBO J       Date:  2006-10-19       Impact factor: 11.598

5.  De novo biosynthetic profiling of high abundance proteins in cystic fibrosis lung epithelial cells.

Authors:  Harvey B Pollard; Ofer Eidelman; Catherine Jozwik; Wei Huang; Meera Srivastava; Xia D Ji; Brighid McGowan; Christine Formas Norris; Tsuyoshi Todo; Thomas Darling; Peter J Mogayzel; Pamela L Zeitlin; Jerry Wright; William B Guggino; Eleanore Metcalf; William J Driscoll; Greg Mueller; Cloud Paweletz; David M Jacobowitz
Journal:  Mol Cell Proteomics       Date:  2006-07-07       Impact factor: 5.911

Review 6.  CFTR chloride channel drug discovery--inhibitors as antidiarrheals and activators for therapy of cystic fibrosis.

Authors:  A S Verkman; Gergely L Lukacs; Luis J V Galietta
Journal:  Curr Pharm Des       Date:  2006       Impact factor: 3.116

7.  Sodium 4-phenylbutyrate downregulates Hsc70: implications for intracellular trafficking of DeltaF508-CFTR.

Authors:  R C Rubenstein; P L Zeitlin
Journal:  Am J Physiol Cell Physiol       Date:  2000-02       Impact factor: 4.249

8.  Post-translational disruption of the delta F508 cystic fibrosis transmembrane conductance regulator (CFTR)-molecular chaperone complex with geldanamycin stabilizes delta F508 CFTR in the rabbit reticulocyte lysate.

Authors:  W Fuller; A W Cuthbert
Journal:  J Biol Chem       Date:  2000-12-01       Impact factor: 5.157

9.  Insertion of an arginine residue into the transmembrane segments corrects protein misfolding.

Authors:  Tip W Loo; M Claire Bartlett; David M Clarke
Journal:  J Biol Chem       Date:  2006-08-22       Impact factor: 5.157

10.  Sequential quality-control checkpoints triage misfolded cystic fibrosis transmembrane conductance regulator.

Authors:  J Michael Younger; Liling Chen; Hong-Yu Ren; Meredith F N Rosser; Emma L Turnbull; Chun-Yang Fan; Cam Patterson; Douglas M Cyr
Journal:  Cell       Date:  2006-08-11       Impact factor: 41.582

View more
  47 in total

1.  Correction of Niemann-Pick type C1 trafficking and activity with the histone deacetylase inhibitor valproic acid.

Authors:  Kanagaraj Subramanian; Darren M Hutt; Samantha M Scott; Vijay Gupta; Shu Mao; William E Balch
Journal:  J Biol Chem       Date:  2020-04-30       Impact factor: 5.157

2.  Enhancing the Potency of F508del Correction: A Multi-Layer Combinational Approach to Drug Discovery for Cystic Fibrosis.

Authors:  Emily F Kirby; Ashley S Heard; X Robert Wang
Journal:  J Pharmacol Clin Toxicol       Date:  2013-08-28

3.  Expanding the proteome: disordered and alternatively folded proteins.

Authors:  H Jane Dyson
Journal:  Q Rev Biophys       Date:  2011-07-01       Impact factor: 5.318

Review 4.  Intracellular α(2C)-adrenoceptors: storage depot, stunted development or signaling domain?

Authors:  Maqsood A Chotani; Nicholas A Flavahan
Journal:  Biochim Biophys Acta       Date:  2011-05-14

5.  SYVN1, NEDD8, and FBXO2 Proteins Regulate ΔF508 Cystic Fibrosis Transmembrane Conductance Regulator (CFTR) Ubiquitin-mediated Proteasomal Degradation.

Authors:  Shyam Ramachandran; Samantha R Osterhaus; Kalpaj R Parekh; Ashley M Jacobi; Mark A Behlke; Paul B McCray
Journal:  J Biol Chem       Date:  2016-10-18       Impact factor: 5.157

6.  A TRPV4 channel C-terminal folding recognition domain critical for trafficking and function.

Authors:  Lei Lei; Xu Cao; Fan Yang; Di-Jing Shi; Yi-Quan Tang; Jie Zheng; KeWei Wang
Journal:  J Biol Chem       Date:  2013-03-02       Impact factor: 5.157

7.  Reduced histone deacetylase 7 activity restores function to misfolded CFTR in cystic fibrosis.

Authors:  Darren M Hutt; David Herman; Ana P C Rodrigues; Sabrina Noel; Joseph M Pilewski; Jeanne Matteson; Ben Hoch; Wendy Kellner; Jeffery W Kelly; Andre Schmidt; Philip J Thomas; Yoshihiro Matsumura; William R Skach; Martina Gentzsch; John R Riordan; Eric J Sorscher; Tsukasa Okiyoneda; John R Yates; Gergely L Lukacs; Raymond A Frizzell; Gerard Manning; Joel M Gottesfeld; William E Balch
Journal:  Nat Chem Biol       Date:  2009-12-06       Impact factor: 15.040

8.  Functional polycystin-1 dosage governs autosomal dominant polycystic kidney disease severity.

Authors:  Katharina Hopp; Christopher J Ward; Cynthia J Hommerding; Samih H Nasr; Han-Fang Tuan; Vladimir G Gainullin; Sandro Rossetti; Vicente E Torres; Peter C Harris
Journal:  J Clin Invest       Date:  2012-10-15       Impact factor: 14.808

9.  Biological and structural basis for Aha1 regulation of Hsp90 ATPase activity in maintaining proteostasis in the human disease cystic fibrosis.

Authors:  Atanas V Koulov; Paul LaPointe; Bingwen Lu; Abbas Razvi; Judith Coppinger; Meng-Qiu Dong; Jeanne Matteson; Rob Laister; Cheryl Arrowsmith; John R Yates; William E Balch
Journal:  Mol Biol Cell       Date:  2010-01-20       Impact factor: 4.138

10.  Interplay between ER exit code and domain conformation in CFTR misprocessing and rescue.

Authors:  Gargi Roy; Elaine M Chalfin; Anita Saxena; Xiaodong Wang
Journal:  Mol Biol Cell       Date:  2009-12-23       Impact factor: 4.138

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.